Menu

Latest news & events

Team Science grant Uyen Nguyen and Roel Meiburg

Team Science grant Uyen Nguyen and Roel Meiburg

18 December 2024

Dr Uyen Nguyen (Dept of Cardiology) and Dr Roel Meiburg (Biomedical Engineer, TU Eindhoven) have been awarded a Dekker Team Science grant by the Dutch Heart Foundation.

Read more
ZonMw grant on appropriate palliative care

ZonMw grant on appropriate palliative care

10 December 2024

Prof. Marc Hemmelder (Dept of Internal Medicine) and his team received a ZonMw grant to promote early palliative care for dialysis patients who are non-waitlisted for transplantation.
 

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Yvonne Henskens

Associate professor

Dr Yvonne Henskens graduated with the specialisations in Biochemistry and Toxicology at Wageningen University. She worked on salivary cystatins in periodontal health and disease at the Department of Oral Biochemistry, Free University Amsterdam/Academic Centre for Dentistry (ACTA). After her PhD she started her specialisation for Clinical Chemistry at the Reinier de Graaf Gasthuis in Delft.

At this moment she is a clinical biochemist, working in laboratories for the past 15 years (Amsterdam Medical Centre and Maastricht UMC+). She has been responsible for the diagnostic tests concerning hematology, hemostasis and transfusion at Maastricht UMC+ since 2003.  She has special research interest in laboratory predictors of bleeding and in pre- and peri-operative management of coagulopathies: Active in the boards of the Dutch societies for hematologicallaboratories and clinical chemistry. Involved in training and education of medical and life sciences students, laboratory technicians and residents. Founder of a re-training programme on hemostasis and transfusion for technicians and clinical biochemists for the south-east part of the Netherlands.

Yvonne-henskens

Central Diagnostic Laboratory MUMC+
Department of Biochemistry
P. Debyelaan 25, 6229 HX Maastricht
Room number: 5.E2.001
T: +31(0)43 387 79 76

  • 2024
    • Mansouritorghabeh, H., Monard, A., Heubel-Moenen, F., Leentjens, J., Stroobants, A., & Henskens, Y. (2024). The Utility of Total Thrombus-Formation Analysis System (T-TAS) in the Thrombosis and Hemostasis Field: A Scoping Review. International Journal of Laboratory Hematology. Advance online publication. https://doi.org/10.1111/ijlh.14403
    • Jooss, N. J., Diender, M. G., Fernandez, D. I., Huang, J., Heubel-Moenen, F. C. J., van der Veer, A., Kuijpers, M. J. E., Poulter, N. S., Henskens, Y. M. C., te Loo, M., & Heemskerk, J. W. M. (2024). Restraining of glycoprotein VI- and integrin a2ß1-dependent thrombus formation by platelet PECAM1. Cellular and Molecular Life Sciences, 81(1), Article 44. https://doi.org/10.1007/s00018-023-05058-2
    • Monard, A. L. L., Mussert, C. M. A., van Duijl, T. T., Kruip, M. J. H. A., Henskens, Y. M. C., van den Biggelaar, M., Schutgens, R. E. G., Schols, S. E. M., Fijnvandraat, K. J., Meijer, K., den Exter, P. L., Nieuwenhuizen, L., van Moort, I., Baker, R. I., O'Donnell, J. S., Cnossen, M. H., Heubel-Moenen, F. C. J. I., & BDUC-iN Study group (2024). Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives. Research and practice in thrombosis and haemostasis, 8(8), Article 102625. https://doi.org/10.1016/j.rpth.2024.102625
    • Rijvers, L., Rijpma, S. R., van Wetten, H. B., Henskens, Y. M. C., & Stroobants, A. K. (2024). International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery. Research and practice in thrombosis and haemostasis, 8(8), Article 102616. https://doi.org/10.1016/j.rpth.2024.102616
    • Willers, V., Krumeich, J. R. L., Hulshof, A.-M., Buise, M. P., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., & Kuiper, G. J. A. J. M. (2024). Comparison of the Quantra QPlus and ROTEM Goal-Directed Transfusion Protocols in Cardiothoracic Surgery Patients: A Prospective Observational Study. Journal of Cardiothoracic and Vascular Anesthesia, 38(11), 2559-2566. https://doi.org/10.1053/j.jvca.2024.07.046
    • Monard, A., Castoldi, E., De Simone, I., Wichapong, K., van Duijl, T., van den Biggelaar, M., Spada, S., van Doorn, W., Hellenbrand, D., van der Meijden, P., Swieringa, F., Stork, A., ten Cate, H., Beckers, E., Heubel-Moenen, F., & Henskens, Y. (2024). Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel FGG mutation. Frontiers in Cardiovascular Medicine, 11, Article 1488602. https://doi.org/10.3389/fcvm.2024.1488602
    • de Jong, M. J., Saadan, H., van der Hooft, B. H. M., Hellenbrand, D. L. S., Brüggemann, R. A. G., Ten Cate, H., van Kuijk, S. M. J., van Geel, R. M. J. M., Henskens, Y. M. C., Winckers, K., & Magdelijns, F. J. H. (2024). Intra-Individual Variability of Direct Oral Anticoagulant Levels in Frail Older Patients upon, during, and after Acute Hospitalization: the DOAC-FRAIL Study. Journal of the American Medical Directors Association, 25(12), Article 105280. Advance online publication. https://doi.org/10.1016/j.jamda.2024.105280
    • Vroemen, W. H. M., Denessen, E. J. S., van Doorn, W. P. T. M., Pelzer, K. E. J. M., Hackeng, T. M., Litjens, E. J. R., Henskens, Y. M. C., van der Sande, F. M., Wodzig, W. K. W. H., Kooman, J. P., Bekers, O., de Boer, D., & Mingels, A. M. A. (2024). Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?Journal of Applied Laboratory Medicine, 9(5), 989-1000. https://doi.org/10.1093/jalm/jfae052
    • Gulikers, J. L., Otten, L.-S., Hendriks, L. E. L., Winckers, K., Henskens, Y., Leentjens, J., van den Heuvel, M. M., Ter Heine, R., Croes, S., Piet, B., & van Geel, R. M. J. M. (2024). Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British Journal of Cancer, 131(3), 481-490. https://doi.org/10.1038/s41416-024-02744-1
    • Haisma, B., Schols, S. E. M., van Oerle, R. G. M., Verbeek-Knobbe, K., Hellenbrand, D., Verwoerd, E. J., Heubel-Moenen, F. C. J. I., Stroobants, A. K., Meijer, D., Rijpma, S. R., & Henskens, Y. M. C. (2024). Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment. Thrombosis Research, 240, Article 109045. https://doi.org/10.1016/j.thromres.2024.109045
    • Meier, R. T., Porcelijn, L., Hofstede-van Egmond, S., Henskens, Y. M. C., Coutinho, J. M., Kruip, M. J. H. A., Stroobants, A. K., Zwaginga, J. J., van der Bom, J. G., van der Schoot, C. E., de Haas, M., & Kapur, R. (2024). Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands. Vox sanguinis, 119(7), 728-736. https://doi.org/10.1111/vox.13633
    • Baker, R. I., Choi, P., Curry, N., Gebhart, J., Gomez, K., Henskens, Y., Heubel-Moenen, F., James, P., Abdul Kadir, R., Kouides, P., Lavin, M., Lordkipanidze, M., Lowe, G., Mumford, A., Mutch, N., Nagler, M., Othman, M., Pabinger, I., Sidonio, R., ... ISTH SSC Von Willebrand Factor, Platelet Physiology and Women’s Health Issues in Thrombosis and Haemostasis. (2024). Standardization of definition and management for bleeding disorder of unknown cause: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 22(7), 2059-2070. https://doi.org/10.1016/j.jtha.2024.03.005
    • de Jong, M. J., Saadan, H., Hellenbrand, D. L. S., Ten Cate, H., Spaetgens, B., Brüggemann, R. A. G., van Kuijk, S. M. J., Winckers, K., Henskens, Y. M. C., & Magdelijns, F. J. H. (2024). The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: An exploratory study. Journal of the American Geriatrics Society, 72(7), 2249-2253. https://doi.org/10.1111/jgs.18894
    • Meier, R. T., Porcelijn, L., Hofstede-van Egmond, S., Caram-Deelder, C., Coutinho, J. M., Henskens, Y. M. C., Kruip, M. J. H. A., Stroobants, A. K., Zwaginga, J. J., van der Schoot, C. E., de Haas, M., & Kapur, R. (2024). Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients. ANTIBODIES, 13(2), Article 35. https://doi.org/10.3390/antib13020035
    • Hulshof, A. M., Nab, L., van Rosmalen, F., de Kok, J., Mulder, M. M. G., Hellenbrand, D., Sels, J. W. E. M., ten Cate, H., Cannegieter, S. C., Henskens, Y. M. C., & van Bussel, B. C. T. (2024). Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort. Thrombosis Research, 234, 51-58. https://doi.org/10.1016/j.thromres.2023.12.010
  • 2023
    • Mulder, M. M. G., Schellens, J., Sels, J.-W. E. M., van Rosmalen, F., Hulshof, A.-M., de Vries, F., Segers, R., Mihl, C., van Mook, W. N. K. A., Bast, A., Spronk, H. M. H., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Schurgers, L. J., Drent, M., & van Bussel, B. C. T. (2023). Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort. Journal of Intensive Care, 11(1), Article 63. https://doi.org/10.1186/s40560-023-00712-0
    • Van de Berg, T. W., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., Henskens, Y. M. C., Thomassen, M. C. L. G. D., & Hackeng, T. M. (2023). Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa. Thrombosis and Haemostasis, 123(11), 1034-1041. https://doi.org/10.1055/a-2101-7961
    • Denessen, E. J. S., Vroemen, W. H. M., Litjens, E. J. R., Henskens, Y. M. C., van der Sande, F. M., Bekers, O., de Boer, D., & Mingels, A. M. A. (2023). Cardiac Troponin T Degradation in End-Stage Renal Disease Patients Appears to Occur in Vivo. Journal of Applied Laboratory Medicine, 8(5), 1000-1002. https://doi.org/10.1093/jalm/jfad043
    • Schultinge, L., Hulshof, A. M., van Neerven, D., Mulder, M. M. G., Sels, J. W. E. M., Hulsewe, H. P. M. G., Kuiper, G. J. A. J. M., Olie, R. H., ten Cate, H., van der Horst, I. C. C., van Bussel, B. C. T., & Henskens, Y. M. C. (2023). Applications of rotational thromboelastometry in heparin monitoring in critical COVID-19 disease: Observations in the Maastricht Intensive Care COVID cohort. Thrombosis Update, 12(1), Article 100140. https://doi.org/10.1016/j.tru.2023.100140
    • Schol, P. B. B., de Lange, N., Henskens, Y., Smits, L. J. M., Smeets, N. A. C., & Scheepers, H. C. J. (2023). Restrictive versus liberal fluid administration strategy (REFILL study) in postpartum hemorrhage and its effects on thromboelastometry (ROTEM®) values: a randomized, controlled trial. Journal of International Medical Research, 51(8), Article 03000605231171007. https://doi.org/10.1177/03000605231171007
    • Fernandez, D. I., Diender, M., Hermida-Nogueira, L., Huang, J., Veiras, S., Henskens, Y. M. C., te Loo, M. W. M., Heemskerk, J. W. M., Kuijpers, M. J. E., & Garcia, A. (2023). Role of SHP2 (PTPN11) in glycoprotein VI-dependent thrombus formation: Improved platelet responsiveness by the allosteric drug SHP099 in Noonan syndrome patients. Thrombosis Research, 228(1), 105-116. https://doi.org/10.1016/j.thromres.2023.06.001
    • Jooss, N. J., Henskens, Y. M. C., Watson, S. P., Farndale, R. W., Gawaz, M. P., Jandrot-Perrus, M., Poulter, N. S., & Heemskerk, J. W. M. (2023). Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type. Thrombosis and Haemostasis, 123(06), 597-612. https://doi.org/10.1055/s-0043-1761463
    • Akbalut, C., Arisz, R., Baaten, C., Baildildinova, G., Barakzie, A., Bauersachs, R., Ten Berg, J. M., van den Broek, W., de Boer, H. C., Broker, V., Buka, R., Ten Cate, H., Cate, A. T., De Luca, C., De Simone, I., Dignat-George, F., Freson, K., Gazzaniga, G., van Gorp, E., ... van Zonneveld, A.-J. (2023). Blood coagulation and beyond: Position paper from the Fourth Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis, 123(8), 808-839. https://doi.org/10.1055/a-2052-9175
    • Braeken, D. C. W., Bavalia, R., Henskens, Y. M. C., Cate, H. T., Hengeveld, R. C. C., Hutten, B. A., Middeldorp, S., Coppens, M., & Stroobants, A. K. (2023). Clinical characteristics of patients with direct oral anticoagulant (DOAC) levels outside expected ranges: A retrospective chart study. Thrombosis Update, 11(1), Article 100139. https://doi.org/10.1016/j.tru.2023.100139
    • Heubel-Moenen, F. C. J. I., Ansems, L. E. M., Verhezen, P. W. M., Wetzels, R. J. H., van Oerle, R. G. M., Straat, R. J. M. H. E., Megy, K., Downes, K., Henskens, Y. M. C., Beckers, E. A. M., & Joore, M. A. (2023). Effectiveness and costs of a stepwise versus an all-in-one approach to diagnose mild bleeding disorders. British Journal of Haematology, 200(6), 792-801. https://doi.org/10.1111/bjh.18570
    • Verboogen, D., Granzen, B., Hudig, C., van de Kerkhof, D., Verhezen, P., de Boer, D., & Henskens, Y. (2023). Heterophilic antibodies leading to falsely positive D-dimer concentration in an adolescent. Research and practice in thrombosis and haemostasis, 7(1), Article 100017. https://doi.org/10.1016/j.rpth.2022.100017
  • 2022
    • Jooss, N. J., Smith, C. W., Slater, A., Montague, S. J., Di, Y., O'Shea, C., Thomas, M. R., Henskens, Y. M. C., Heemskerk, J. W. M., Watson, S. P., & Poulter, N. S. (2022). Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation. Journal of Thrombosis and Haemostasis, 20(11), 2617-2631. https://doi.org/10.1111/jth.15836
    • van de Berg, T. W., Mulder, M. M. G., Alnima, T., Nagy, M., van Oerle, R., Beckers, E. A. M., Hackeng, T. M., Hulshof, A. M., Sels, J. W. E. M., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & Dutch COVID & Thrombosis Coalition (2022). Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort. Frontiers in Cardiovascular Medicine, 9, Article 929284. https://doi.org/10.3389/fcvm.2022.929284
    • Jooss, N. J., Smith, C. W., Pike, J. A., Farndale, R. W., Henskens, Y. M. C., Watson, S. P., Heemskerk, J. W. M., & Poulter, N. S. (2022). Platelet glycoprotein VI cluster size is related to thrombus formation and phosphatidylserine exposure in collagen-adherent platelets under arterial shear. Journal of Thrombosis and Haemostasis, 21(8), 2260-2267. https://doi.org/10.1016/j.jtha.2023.04.028
    • Denessen, E. J. S., Van den Kerkhof, D. L., Jeurissen, M. L. J., Wetzels, R. J. H., Verhezen, P. W. M., & Henskens, Y. M. C. (2022). Determining the Optimal Storage Time and Temperature for Performing Platelet Function Assays and Global Hemostasis Assays. Platelets, 33(3), 416-424. https://doi.org/10.1080/09537104.2021.1934666
    • Heubel-Moenen, F. C. J. I., Brouns, S. L. N., Herfs, L., Boerenkamp, L. S., Jooss, N. J., Wetzels, R. J. H., Verhezen, P. W. M., Machiels, P., Megy, K., Downes, K., Heemskerk, J. W. M., Beckers, E. A. M., & Henskens, Y. M. C. (2022). Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time. British Journal of Haematology, 196(6), 1388-1400. https://doi.org/10.1111/bjh.18003
    • Post, D. S., van der Veer, A., Schijns, O. E. M. G., Klinkenberg, S., Rijkers, K., Wagner, G. L., van Kranen-Mastenbroek, V. H. J. M., Willems, P. C. P. H., Verhezen, P. W. M., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., & Henskens, Y. M. C. (2022). Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study. PLOS ONE, 17(2), Article e0264351. https://doi.org/10.1371/journal.pone.0264351
  • 2021
    • Hulshof, A.-M., Olie, R. H., Vries, M. J. A., Verhezen, P. W. M., van der Meijden, P. E. J., Ten Cate, H., & Henskens, Y. M. C. (2021). Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention. Frontiers in Cardiovascular Medicine, 8, Article 788137. https://doi.org/10.3389/fcvm.2021.788137
    • Schol, P. B. B., de Lange, N. M., Smits, L. J. M., Henskens, Y. M. C., & Scheepers, H. C. J. (2021). Thromboelastometry in daily obstetric practice: At what amount of blood loss do we find abnormal results? A retrospective clinical observational study. Thrombosis Research, 207, 140-142. https://doi.org/10.1016/j.thromres.2021.09.015
    • Olie, R. H., van der Meijden, P. E. J., Vries, M. J. A., Veenstra, L., van't Hof, A. W. J., ten Berg, J. M., Henskens, Y. M. C., & ten Cate, H. (2021). Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse events. Netherlands Heart Journal, 29(10), 525-535. https://doi.org/10.1007/s12471-021-01606-2
    • Olie, R. H., Hensgens, R. R. K., Wijnen, P. A. H. M., Veenstra, L. F., de Greef, B. T. A., Vries, M. J. A., van der Meijden, P. E. J., ten Berg, J. M., ten Cate, H., Bekers, O., & Henskens, Y. M. C. (2021). Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients. Journal of Clinical Medicine, 10(17), Article 3992. https://doi.org/10.3390/jcm10173992
    • Hulshof, A. M., Braeken, D. C. W., Ghossein-Doha, C., van Santen, S., Sels, J. W. E. M., Kuiper, G. J. A. J. M., van der Horst, I. C. C., ten Cate, H., van Bussel, B. C. T., Olie, R. H., & Henskens, Y. M. C. (2021). Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge. Research and practice in thrombosis and haemostasis, 5(6), Article e12579. https://doi.org/10.1002/rth2.12579
    • Herfs, L., Swieringa, F., Jooss, N., Kozlowski, M., Heubel-Moenen, F. C. J., van Oerle, R., Machiels, P., Henskens, Y., & Heemskerk, J. W. M. (2021). Multiparameter microfluidics assay of thrombus formation reveals increased sensitivity to contraction and antiplatelet agents at physiological temperature. Thrombosis Research, 203, 46-56. https://doi.org/10.1016/j.thromres.2021.04.014
    • Schol, P. B. B., de Lange, N. M., Woiski, M. D., Langenveld, J., Smits, L. J. M., Wassen, M. M., Henskens, Y. M., & Scheepers, H. C. J. (2021). Restrictive versus liberal fluid resuscitation strategy, influence on blood loss and hemostatic parameters in mild obstetric hemorrhage: An open-label randomized controlled trial. (REFILL study). PLOS ONE, 16(6), Article e0253765. https://doi.org/10.1371/journal.pone.0253765
    • de Breet, C. P. D. M., Zwaveling, S., Vries, M. J. A., van Oerle, R. G., Henskens, Y. M. C., Van't Hof, A. W. J., van der Meijden, P. E. J., Veenstra, L., ten Cate, H., & Olie, R. H. (2021). Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy. Frontiers in Cardiovascular Medicine, 8, Article 679934. https://doi.org/10.3389/fcvm.2021.679934
    • Mulder, M. M. G., Brandts, LI., Brüggemann, R. A. G., Koelmann, M., Streng, A. S., Olie, R. H., Gietema, H. A., Spronk, H. M. H., van der Horst, I. C. C., Sels, J.-W. E. M., Wildberger, J. E., van Kuijk, S. M. J., Schnabel, R. M., Ten Cate, H., Henskens, Y. M. C., & van Bussel, B. C. T. (2021). Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort. Thrombosis Journal, 19(1), Article 35. https://doi.org/10.1186/s12959-021-00286-7
    • Munnix, I. C. A., Van Oerle, R., Verhezen, P., Kuijper, P., Hackeng, C. M., Hopman-Kerkhoff, H. I. J., Hudig, F., Van De Kerkhof, D., Leyte, A., De Maat, M. P. M., Elferink, R. F. M. O., Ruinennans-Koerts, J., Schoorl, M., Slomp, J., Soons, H., Stroobants, A., Van Wijk, E., & Henskens, Y. M. C. (2021). Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline. Platelets, 32(4), 516-523. https://doi.org/10.1080/09537104.2020.1771549
    • Hulshof, A. M., Vries, M., Verhezen, P., Wetzels, R., Haartmans, M., Olie, R., Ten Cate, H., & Henskens, Y. (2021). The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy. Platelets, 32(4), 463-468. https://doi.org/10.1080/09537104.2020.1754378
    • Bavalia, R., Veenhuizen, J. E., Hengeveld, R. C. C., Braeken, D., Gulpen, A. J. W., Ten Cate, H., Middeldorp, S., Henskens, Y. M. C., Hutten, B. A., Coppens, M., & Stroobants, A. K. (2021). Direct oral anticoagulant blood level monitoring in daily practice. Thrombosis Update, 3, Article 100049. https://doi.org/10.1016/j.tru.2021.100049
    • Gresele, P., Falcinelli, E., Bury, L., Pecci, A., Alessi, M. C., Borhany, M., Heller, P. G., Santoro, C., Cid, A. R., Orsini, S., Fontana, P., De Candia, E., Podda, G., Kannan, M., Jurk, K., Castaman, G., Falaise, C., Guglielmini, G., Noris, P., ... BAT-VAL Study Investigators (2021). The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology. Journal of Thrombosis and Haemostasis, 19(5), 1364-1371. https://doi.org/10.1111/jth.15263
    • van de Berg, T. W., Hulshof, A.-M. M., Nagy, M., van Oerle, R., Sels, J.-W., van Bussel, B., Ten Cate, H., Henskens, Y., Spronk, H. M. H., & Dutch Covid-19 and Thrombosis Coalition (2021). Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability. Thrombosis Research, 201, 84-89. https://doi.org/10.1016/j.thromres.2021.02.026
    • Hulshof, A.-M., Brüggemann, R. A. G., Mulder, M. M. G., van de Berg, T. W., Sels, J.-W. E. M., Olie, R. H., Spaetgens, B., Streng, A. S., Verhezen, P., van der Horst, I. C. C., Ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & Henskens, Y. M. C. (2021). Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation. Frontiers in Cardiovascular Medicine, 8, Article 654174. https://doi.org/10.3389/fcvm.2021.654174
    • Hulshof, A.-M., Hemker, H. C., Spronk, H. M. H., Henskens, Y. M. C., & Ten Cate, H. (2021). Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis. International journal of molecular sciences, 22(5), Article 2590. https://doi.org/10.3390/ijms22052590
  • 2020
    • Denessen, E. J. S., Jeurissen, M. L. J., Pereboom, R. M. T. A., Verhezen, P. W. M., & Henskens, Y. M. C. (2020). Determining the maximal storage time of centrifuged citrated samples for performing add-on routine coagulation tests. Thrombosis Research, 196, 54-62. https://doi.org/10.1016/j.thromres.2020.08.003
Overview